Opioid Antagonist Speeds Abdominal Surgery Recovery
BOSTON-A frequent problem with abdominal surgery is afterward, the digestive system has a tendency to shut down for several days. This extends a patient's recovery time, increasing healthcare costs and the time demanded on the hospital per patient.
A new analgesic created in the labs of the biopharmaceutical company Adolor Corp., may reduce both the cost and recovery time associated with abdominal surgery by helping the digestive tract function properly.
ADL 8-2698 is a new opioid antagonist that reportedly does not cross the blood-brain barrier, meaning the drug can relieve pain during recovery. Pharmaceuticals usually given during abdominal surgeries, including morphine and other opium-based painkillers, tend to aggravate the digestive tract. Because ADL 8-2698 is an opioid antagonist-a synthetic narcotic not derived from opium, the condition does not occur.
A trial of the drug was conducted on 79 patients who were set to undergo hysterectomies or partial removal of the colon. With surgery being cancelled for one patient, the group was left with 15 undergoing partial colectomies and 63 having total abdominal hysterectomies. The group was randomly split and given either the drug or a placebo.
The ADL 8-2698 group received one capsule 2 hours before their surgery and then one twice daily after surgery until they had their first bowel movement. These patients had a significantly faster recovery time of 70 hours compared to those patients who received a placebo. The placebo group recovered on average after 111 hours.
The opioid antagonist had been tested previously to control the pain of patients undergoing other procedures, but this was the first study examining the affects of the drug on abdominal surgeries.
For more information about Exton, Pa based Adolor Corp., log onto: www.adolor.com
Information from www.givenimaging.com, Reuters Health
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Why Clinical Expertise Is the Cornerstone to Your Most Profitable Business Line
November 14th 2024Perioperative nurses bring vital skills in patient safety, infection control, and quality improvement. They enhance surgical outcomes and support health care systems during complex, high-risk procedures.
Strengthening Defenses: Integrating Infection Control With Antimicrobial Stewardship
October 11th 2024Use this handout to explain the basics of why infection prevention and control and antimicrobial stewardship are essential and how the 2 fields must have a unified approach to patient and staff safety
Blood Product Overtransfusion Is a Global Issue: Here Are 5 Reasons the Practice Must Change
October 9th 2024If a patient receives treatment or therapy that they do not need, it can cause unnecessary harm. This is true for medications, surgeries, and medical procedures, especially blood transfusions.
